<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01355939</url>
  </required_header>
  <id_info>
    <org_study_id>2011-02112</org_study_id>
    <secondary_id>1KM1CA156708-01</secondary_id>
    <nct_id>NCT01355939</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh</brief_title>
  <official_title>A Prospective Multicenter Trial to Evaluate Adhesion Characteristics and Adhesiolysis-related Complications of Barrier-coated and Non-barrier-coated Intraperitoneal Mesh During Abdominal Re-exploration After Prior Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Atrium Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will compare the benefits, harms, and comparative effectiveness of
      intraperitoneal barrier-coated and non-barrier coated ventral hernia repair (VHR) mesh in
      reducing adhesions, adhesion-related complications, and adhesiolysis sequelae in actual
      patient subpopulations and clinical circumstances. A subset of the data will be analyzed to
      compare the benefits, harms, and comparative effectiveness of the laparoscopic and open
      approaches to adhesiolysis. A comprehensive array of health-related risk factors and
      patient-centered outcomes will be assessed in the investigators diverse patient population
      for proper multivariate data analysis.

      Specific Aim I: To evaluate and compare the adhesion characteristics of intraperitoneal
      barrier-coated versus non-barrier-coated mesh during abdominal re-exploration after prior
      ventral hernia repair.

      Specific Aim II: To evaluate and compare the adhesion-related complications and
      adhesiolysis-related complications of intraperitoneal barrier-coated versus
      non-barrier-coated mesh during abdominal re-exploration after prior ventral hernia repair.

      Specific Aim III: To determine the comparative effectiveness of intraperitoneal
      barrier-coated versus non-barrier-coated ventral hernia repair mesh in reducing adhesions,
      adhesion-related complications, and adhesiolysis sequelae in actual patient subpopulations
      and clinical circumstances.

      Specific Aim IV: To evaluate and compare the adhesiolysis-related complications of the
      laparoscopic and open approaches to adhesiolysis during abdominal re-exploration after prior
      ventral hernia repair.

      Specific Aim V: To determine the comparative effectiveness of the laparoscopic and open
      approaches to adhesiolysis during abdominal re-exploration after prior ventral hernia repair.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mesh adhesiolysis time:Mesh surface area</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mesh Contracture</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mesh adhesion tenacity</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage mesh surface area covered with adhesions</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adhesiolysis time to abdominal wall</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adhesiolysis time to mesh</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adhesiolysis-related intra-operative complications</measure>
    <time_frame>Intraoperatively (day 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay of hospital admission</measure>
    <time_frame>30 day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>30 day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interval to return to bowel function</measure>
    <time_frame>30 day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interval to return to independent ambulation or activities of daily living</measure>
    <time_frame>30 day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interval to return to work or routine physical activity</measure>
    <time_frame>30 day postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative complications</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of surgical site infection</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of initiation of antibiotics, blood and total parenteral nutrition</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of bedside procedures to address a postoperative surgical complication</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of surgery under local anesthesia to address a postoperative complication</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of single system organ failure</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of multiple-system organ failure</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>30 day, 12 month, and 24 month postoperative</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">173</enrollment>
  <condition>Ventral Hernia</condition>
  <condition>Adhesions</condition>
  <arm_group>
    <arm_group_label>Abdominal surgery after prior VHR with barrier-coated mesh</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal surgery after prior VHR with nonbarrier-coated mesh</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Lap adhesiolysis during abdominal surgery after prior VHR</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Open adhesioloysis during abdominal surgery after prior VHR</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Clinically-Indicated Abdominal Re-Exploration Surgery</intervention_name>
    <description>This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.</description>
    <arm_group_label>Abdominal surgery after prior VHR with barrier-coated mesh</arm_group_label>
    <arm_group_label>Abdominal surgery after prior VHR with nonbarrier-coated mesh</arm_group_label>
    <arm_group_label>Lap adhesiolysis during abdominal surgery after prior VHR</arm_group_label>
    <arm_group_label>Open adhesioloysis during abdominal surgery after prior VHR</arm_group_label>
    <other_name>Bard(TM) Mesh</other_name>
    <other_name>PROLENE(TM)</other_name>
    <other_name>ProLite(TM)</other_name>
    <other_name>ProLite(TM) Ultra(TM)</other_name>
    <other_name>Bard(TM) Soft Mesh</other_name>
    <other_name>PROLENE(TM) Soft</other_name>
    <other_name>Parietex(TM) Flat Sheet TEC</other_name>
    <other_name>INFINIT(TM) Mesh</other_name>
    <other_name>C-QUR Lite(TM)</other_name>
    <other_name>ULTRAPRO(TM)</other_name>
    <other_name>PROLENE(TM) Hernia System</other_name>
    <other_name>Bard(TM) Mesh PerFix Plug</other_name>
    <other_name>Bard(TM) Ventralex</other_name>
    <other_name>C-QUR(TM) Mesh</other_name>
    <other_name>PROCEED(TM)</other_name>
    <other_name>Bard(TM) Sepramesh(TM) IP Composite</other_name>
    <other_name>Parietex(TM) Composite</other_name>
    <other_name>PHYSIOMESH(TM)</other_name>
    <other_name>Bard(TM) Composix(TM) E/X</other_name>
    <other_name>Bard(TM) Composix(TM) L/P</other_name>
    <other_name>DUALMESH(R)</other_name>
    <other_name>DUALMESH(R) Plus</other_name>
    <other_name>VICRYL(TM)</other_name>
    <other_name>TIGR(R) Matrix</other_name>
    <other_name>Gore (R) Bio-A(R)</other_name>
    <other_name>AlloDerm(R)</other_name>
    <other_name>AlloMax(TM)</other_name>
    <other_name>FlexHD(R)</other_name>
    <other_name>Biodesign(TM) Surgisis(R)</other_name>
    <other_name>Strattice(TM)</other_name>
    <other_name>XenMatrix(TM)</other_name>
    <other_name>Veritas(R)</other_name>
    <other_name>SurgiMend(R)</other_name>
    <other_name>Peri-Guard(R)</other_name>
    <other_name>Permacol(TM)</other_name>
    <other_name>CollaMend(TM) FM</other_name>
    <other_name>CollaMend(TM)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators' patient population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  greater than or equal to 18 years of age

          -  prior ventral hernia repair with intraperitoneal placement of mesh (open or
             laparoscopic approach; absorbable barrier-coated mesh, permanent barrier-coated
             composite mesh, permanent barrier-coated noncomposite mesh, non-barrier-coated
             polypropylene mesh, or biologic mesh)

          -  subsequent abdominal procedure requiring exposure of entire surface area of
             intraperitoneal mesh

        Exclusion Criteria:

          -  less than 18 years of age

          -  inability to verify intraperitoneal mesh type or location

          -  active abdominal wound infection or open abdominal wound
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Brunt, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic Scottsdale</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California-San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2011</study_first_submitted>
  <study_first_submitted_qc>May 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2011</study_first_posted>
  <last_update_submitted>February 19, 2015</last_update_submitted>
  <last_update_submitted_qc>February 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hernia</keyword>
  <keyword>Adhesiolysis</keyword>
  <keyword>Adhesions</keyword>
  <keyword>Intraperitoneal Mesh</keyword>
  <keyword>Abdominal Re-exploration</keyword>
  <keyword>Mesh</keyword>
  <keyword>Barrier-Coated Mesh</keyword>
  <keyword>Non-Barrier-Coated Mesh</keyword>
  <keyword>Laparoscopic Approach</keyword>
  <keyword>Open Approach</keyword>
  <keyword>Abdominal Re-Exploration Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Tissue Adhesions</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

